Gutierrez JA, Heizer GM, Jones WS, Rockhold FW, et al. CYP2C19 status and risk of major adverse cardiovascular events in peripheral artery disease: Insights from the EUCLID Trial. Am Heart J 2020;229:118-120.
PMID: 32950849